CAREDX
CDNAServices-Medical Laboratories · Avg daily volume 1.2M · fiscal year ends Dec$64.69−0.74−1.13%Volume 1.2M−5% vs avg
10-day20-day50-day200-dayRS line vs S&P 500▲ earnings filed, EPS vs a year agoQ3 EPS due in ~20 days
2026-10-14O 64.40 H 67.73 L 63.34 C 64.69 (−1.13%)Vol 1.2M10 64.9220 62.0550 54.14200 30.55RS line 8.406RS rating 99
| FY (Dec) | EPS $ | Chg | High | Low |
|---|---|---|---|---|
| 2018 | -3.93 | +45% | – | – |
| 2019 | -1.56 | +60% | – | – |
| 2020 | -1.20 | +23% | – | – |
| 2021 | -1.77 | −48% | – | – |
| 2022 | -4.32 | −144% | – | – |
| 2023 | -10.62 | −146% | – | – |
| 2024 | 2.79 | +126% | 35 | 7 |
| 2025 | -0.40 | −114% | 26 | 11 |
| TTM | 2.07 | 73 | 14 |
Ratings & facts
RS Rating99
Days at RS 90+23
Setup checks3 / 3
EPS chg, last qtr+1,394%
EPS accelerating3 qtrs ✓
Sales chg, last qtr+52%
P/E (last 4 qtrs)31.3
Mkt cap$3.35B
Off 52-wk high-10.8%
Quarterly earnings
Latest filing: 10-Q, 2026-07-30Mar ’24FQ1 ’24
Jun ’24FQ2 ’24
Sep ’24FQ3 ’24
Dec ’24Q4FQ4 ’24
Mar ’25FQ1 ’25
Jun ’25FQ2 ’25
Sep ’25FQ3 ’25
Dec ’25Q4FQ4 ’25
Mar ’26FQ1 ’26
Jun ’26FQ2 ’26
EPS
EPS
−$0.96
−$0.09
−$0.42
$3.36
−$0.57
−$0.16
$0.03
−$0.08
$0.05
$2.07
% chg
+27%
+94%
+67%
+151%
+41%
−78%
+107%
−102%
+109%
+1,394%
Sales
72.0M
92.3M
82.9M
86.6M
84.7M
86.7M
100.1M
108.4M
117.7M
131.9M
% chg
−7%
+31%
+23%
+32%
+18%
−6%
+21%
+25%
+39%
+52%
Filed
05/09
07/31
11/04
02/28
04/30
08/06
11/04
02/25
04/28
07/30
EPS growth ≥ 25%0–25%fallingno comparison
Source: SEC EDGAR 10-Q and 10-K filings, loaded the first time a stock is opened and refreshed daily. Q4 = full year minus the first three quarters. Growth from a loss is measured against the size of the loss (−$1 → $2 = +300%). Analyst estimates are not in EDGAR.